Lansoprazole sodium

Overview

Lansoprazole sodium (AG 1749 sodium) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole sodium (AG 1749 sodium) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Gastric Disease | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Breast Cancer | Products > Disease Areas > Helicobacter Pylori Infection | Products > Signaling Pathways > Cytoskeleton | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Exosomes | Products > Signaling Pathways > Proton Pump | Products > Signaling Pathways > Phospholipase | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-13662A
• CAS No.: 226904-00-3
• Molecular Formula: C16H13F3N3NaO2S
• Molecular Weight: 391.34
• Purity: 98.80%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source